And I think Southoz is clearly the resident expert in clinical trial stats, so if you don't mind I prefer his opinion over your good self and the other posters. He also set out his reasoning and I don't see any reason not to accept it.
CEO Itescu needs to go, page-147
-
- There are more pages in this discussion • 761 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
-0.010(0.91%) |
Mkt cap ! $1.250B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.09 | $1.08 | $211.1K | 194.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 144670 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 44473 | 7 |
View Market Depth
| Last trade - 10.07am 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |